Last 48 quarters of trend data · Healthcare · Medical - Healthcare Plans
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -3.30 | — | — | — | 5.77 | 27.04 | 13.84 | 7.67 | 9.08 | 221.65 | 19.79 | 8.78 | 7.75 |
| — | — | — | — | -36.5% | -87.8% | -30.1% | -12.6% | +17.3% | — | +29.2% | — | -47.0% | |
| P/S Ratio | 0.11 | 0.10 | 0.09 | 0.14 | 0.16 | 0.19 | 0.23 | 0.22 | 0.26 | 0.25 | 0.25 | 0.25 | 0.23 |
| — | -45.5% | -62.4% | -37.8% | -37.9% | -26.3% | -4.3% | -10.5% | +16.1% | -21.7% | -22.2% | -28.2% | -32.7% | |
| P/B Ratio | 1.10 | 1.01 | 0.83 | 0.97 | 1.08 | 1.15 | 1.44 | 1.28 | 1.56 | 1.54 | 1.47 | 1.44 | 1.39 |
| — | -11.8% | -42.1% | -24.0% | -30.8% | -25.4% | -2.0% | -11.0% | +12.2% | -18.9% | -16.9% | -22.6% | -23.3% | |
| P/FCF | 5.11 | 22.55 | 3.83 | 4.25 | 5.50 | — | — | 4.42 | — | — | 10.53 | 3.98 | 2.16 |
| — | — | — | -4.0% | — | — | — | +11.1% | — | — | +187.7% | -0.9% | -84.2% | |
| EV / EBITDA | — | — | — | — | 4.56 | 18.29 | 10.85 | 5.73 | 7.54 | 85.91 | 8.98 | 6.90 | 6.61 |
| — | — | — | — | -39.5% | -78.7% | +20.8% | -16.9% | +14.1% | -42.1% | -41.9% | -88.9% | -29.0% | |
| EV / EBIT | — | — | — | — | 4.40 | 17.23 | 9.67 | 5.20 | 6.46 | 50.22 | 10.06 | 6.47 | 6.49 |
| — | — | — | — | -31.8% | -65.7% | -3.9% | -19.6% | -0.5% | -21.7% | -8.4% | — | -44.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Centene Corporation's operating margin was -3.5% in Q4 2025, up 10.5 pp QoQ and down 3.9 pp YoY. Gross margin expanded 66.5% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 12.2% | 15.2% | 16.4% | 6.0% | 11.2% | 9.1% | 9.6% | 11.1% | 11.5% | 9.3% | 12.0% | 12.0% | 11.8% |
| — | +66.5% | +70.5% | -45.6% | -2.9% | -1.7% | -19.7% | -7.7% | -2.3% | -14.3% | +8.0% | -3.5% | +0.5% | |
| Operating Margin | -3.9% | -3.5% | -14.0% | -0.9% | 3.3% | 0.4% | 1.6% | 3.1% | 2.7% | -0.5% | 1.9% | 3.1% | 3.1% |
| — | -916.0% | -984.3% | -130.5% | +20.2% | +187.2% | -18.1% | -0.9% | -12.6% | +38.0% | +45.6% | +967.3% | -7.1% | |
| Net Margin | -3.4% | -2.2% | -13.3% | -0.5% | 2.8% | 0.7% | 1.7% | 2.9% | 2.9% | 0.1% | 1.2% | 2.8% | 2.9% |
| — | -419.0% | -886.5% | -118.0% | -2.3% | +508.3% | +37.6% | +2.3% | -0.9% | +119.0% | -40.1% | +687.8% | +27.3% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -28.7% | -5.4% | -27.3% | -0.9% | 4.8% | 1.0% | 2.6% | 4.2% | 4.4% | 0.2% | 1.8% | 4.2% | 4.6% |
| — | -610.8% | -1150.8% | -121.7% | +9.6% | +499.1% | +41.9% | +1.3% | -4.1% | +120.5% | -35.3% | +751.6% | +46.6% | |
| ROA | -8.4% | -1.4% | -7.9% | -0.3% | 1.5% | 0.3% | 0.9% | 1.4% | 1.4% | 0.1% | 0.6% | 1.3% | 1.4% |
| — | -503.2% | -1013.5% | -121.1% | +11.2% | +545.7% | +53.6% | +8.4% | -1.6% | +119.7% | -38.3% | +708.2% | +34.3% | |
| ROIC | -22.2% | -6.4% | -20.0% | -1.1% | 3.6% | 0.4% | 1.7% | 3.4% | 3.0% | -0.5% | 2.0% | 2.9% | 2.8% |
| — | -1608.8% | -1261.4% | -133.0% | +20.6% | +178.1% | -12.0% | +16.4% | +6.2% | +16.3% | +85.2% | +1205.6% | +13.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.87 | 0.87 | 0.84 | 0.64 | 0.65 | 0.73 | 0.64 | 0.64 | 0.67 | 0.73 | 0.75 | 0.83 | 0.86 |
| — | +18.9% | +30.0% | -0.5% | -1.7% | +0.8% | -14.6% | -22.5% | -22.6% | -17.4% | -10.8% | -1.0% | +4.0% | |
| Debt / EBITDA | — | — | — | — | 9.91 | 39.73 | 18.00 | 11.48 | 12.73 | 156.01 | 17.97 | 14.27 | 14.03 |
| — | — | — | — | -22.2% | -74.5% | +0.1% | -19.5% | -9.2% | -32.0% | -30.2% | -85.0% | +1.7% | |
| Current Ratio | 1.10 | 1.10 | 1.08 | 1.10 | 1.11 | 1.11 | 1.10 | 1.17 | 1.17 | 1.11 | 1.12 | 1.11 | 1.07 |
| — | -0.8% | -1.3% | -6.4% | -5.2% | -0.1% | -2.3% | +5.4% | +10.1% | +4.9% | +5.8% | -0.0% | +1.7% | |
| Quick Ratio | 1.10 | 1.10 | 1.08 | 1.10 | 1.11 | 1.11 | 1.10 | 1.17 | 1.17 | 1.11 | 1.12 | 1.11 | 1.07 |
| — | -0.8% | -1.3% | -6.4% | -5.2% | -0.1% | -2.3% | +5.4% | +10.1% | +4.9% | +5.8% | -0.0% | +1.7% | |
| Interest Coverage | -11.24 | -10.36 | -40.91 | -2.69 | 9.02 | 1.02 | 3.78 | 6.98 | 6.21 | -1.06 | 4.06 | 6.47 | 6.77 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonCentene Corporation's current P/E is -3.3x. The average P/E over the last 1 quarters is 5.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Centene Corporation's current operating margin is -3.9%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Centene Corporation's business trajectory between earnings reports.